MedTrace Logo

Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI

NCT01569568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2024-03-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to use various types of MRI and cognitive testing to evaluate changes in the brain and cognitive function that occur in subjects with ornithine transcarbamylase deficiency (OTCD) relative to healthy individuals

Conditions

  • Ornithine Transcarbamylase Deficiency

Interventions

OTHER

MRI scanning

1H MRS, DTI, FMRI

BEHAVIORAL

Cognitive testing

Behavioral testing

Sponsors & Collaborators

  • Children's National Research Institute

    collaborator OTHER

  • Andrea Gropman

    lead OTHER

Principal Investigators

  • Andrea L Gropman, M.D. · Children's National Research Institute

Eligibility

Min Age
7 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2014-08-31
Completion
2014-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569568 on ClinicalTrials.gov